Low density lipoprotein receptor up-regulation

Bibliography

• BORGIA MC, MEDICI F: Perspectives in the treatment of dyslipidemias in the prevention of coronary heart dis-ease. Angiology (1998) 49:339–348.
   PubMedGoogle Scholar
• ROSENSON RS, TANGNEY CC: Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA (1998) 279:1643–1650.
   PubMed Web of Science ®Google Scholar
• YEE HS, FONG NT: Atorvastatin in the treatment of pri-mary hypercholesterolemia and mixed dyslipidemias. Ann. Pharmacother. (1998) 32:1030–1043.
   PubMedGoogle Scholar
• GOLDSTEIN JL, BROWN MS: Regulation of the mevalo-nate pathway. Nature (1990) 343:425–430.
   PubMed Web of Science ®Google Scholar
• BROWN MS, GOLDSTEIN JL: The SREBP pathway: regu-lation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell (1997) 89:331–340.
   PubMed Web of Science ®Google Scholar
• ••An excellent overview of SREBP.
   Google Scholar
• ATHANIKAR JN, SANCHEZ HB, OSBORNE TF: Promoter selective transcriptional synergy mediated by sterol regulatory element binding protein and Spl: a critical role for the Btd domain of Spl. Mol. Cell. Biol. (1997) 17:5193–5200.
   PubMedGoogle Scholar
• LANGE Y, DUAN H, MAZZONE T: Cholesterol homeosta-sis is modulated by amphiphiles at transcriptional and post-transcriptional loci. J. Lipid Res. (1996) 37:534–539.
   PubMedGoogle Scholar
• CHANG G, CUMMINGS DS, HELIN JP et al: Evaluation of benzimidazoles as upregulators of the low density lipoprotein (LDI) receptor. 211th ACS National Meeting. New Orleans, USA (1996). MEDI–155.
   Google Scholar
• •Presentation showing that tubulin inhibitors up-regulate LDLr.
   Google Scholar
• BROWN MS, GOLDSTEIN JL: Regulation of the activity of the low density lipoprotein receptor in human fibro-blasts. Cell (1975) 6:307–316.
   PubMed Web of Science ®Google Scholar
• DAWSON PA, HOFMANN SL, VAN DER WESTHUYZEN DR et al.: Sterol-dependent repression of low density lipo-protein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription fac-tor Sp 1. J. Biol. Chem. (1988) 263:3372–3379.
   Google Scholar
• CUTHBERT JA, RUSSELL DW, LIPSKY PE: Regulation of low density lipoprotein receptor gene expression in human lymphocytes. J. Biol. Chem. (1989) 264:1298–1304.
   PubMedGoogle Scholar
• ELLSWORTH JL, CARLSTROM AJ, DEIKMAN J: Ketocona-zole and 25-hydroxycholesterol produce reciprocal changes in the rate of transcription of the human LDL receptor gene. Biochem. Biophys. Acta (1994) 1210:321–328.
   PubMedGoogle Scholar
• UN HS, RAMPERSAUD AA, ARCHER RA et al: Synthesis and biological evaluation of a new series of sterols as potential hypocholesterolemic agents. J. Med. Chem. (1995) 38:277–288.
   PubMedGoogle Scholar
• UN HS, RAMPERSAUD AA, RICHETT ME et al: Synthesis of 4a-(2-propeny1)-5,6-secocholestan-3a-ol, a novel B-ring seco analog of the hypocholesterolemic agent 4a- (2-propeny1)-5a-cholestan-3a-ol. Steroids (1998) 63:202–207.
   PubMedGoogle Scholar
• ASHTON MJ, BROWN TJ, FENTON G et al: New low-density lipoprotein receptor upregulators acting via a novel mechanism. J. Med. Chem. (1996) 39:3343–3356.
   PubMed Web of Science ®Google Scholar
• BROWN TJ, WHITE A, LLOYD J et al.: RPR102359 upregu-lates LDL receptors in a cultured juman hepatocyte cell line by a sterol-independent mechanism. Atherosclero-sis (1994) 109:113–114.
   Google Scholar
• HUETTINGER M, HERMANN M, GOLDENBERG H, GRAN-ZER E, LEINEWEBER M: Hypolipidemic activity of HOE-402 is mediated by stimulation of the LDL receptor pathway. Arterioscler. Thromb. (1993), 13:1005–1012.
   PubMedGoogle Scholar
• HOFFMANN A, SCHMALZ M, LEINEWEBER M: Choles-terol lowering action of HOE 402 in the normolipi-demic and hypercholesterolemic Golden Syrian hamster. Biochim. Biophys. Acta (1996) 1299:95–102.
   PubMedGoogle Scholar
• DRAIJER R, VOLGER OL, DAHLMANS V et al.: The hypolipidemic compound H0E402 reduces VLDL-lipid production and atherosclerosis in hetero- and homo-zygous LDLr-deficient mice. XIII International Sympo-sium on Drug Affecting Lipid Metabolism. Florence, Italy (1998) 95.
   Google Scholar
• CHANG G, CUMMINGS DS, HELIN JP et al.: Evaluation of pyrimidones as upregulators of the low density lipo-protein (LDL) receptor. 2 16th A CS National Meeting. Bos-ton, USA (1998). MEDI–067.
   Google Scholar
• CHANG G, CUMMINGS DS, GILLASPY ML et al.: Explora-tion of the SAR of CP-230,821 for the upregulation of the LDL Receptor. 208th ACS National Meeting. Washing-ton, DC, USA (1994). MEDI–237.
   Google Scholar
• CHANG G, CUMMINGS DS, GILLASPY ML et al.: Discovery of CP-230,821: upregulator of the LDL receptor for the treatment of hypercholesterolemia. Atherosclerosis (1994) 109:309.
   Google Scholar
• SHIMOKAWA T, GOTO S, IDA M et al.: Hypocholestero-lemic effects of the LDL receptor gene transcriptional upregulator CP-230821. J. Biochem. (1998) 123:596–601.
   PubMedGoogle Scholar
• DEKKER KA, AIELLO RJ, HIRAI H et al.: Novel lactone compounds from Mortierella verticillata that induced the human low density lipoprotein receptor gene: fer-mentation, isolation, structural elucidation and bio-logical activities. J. Antibiotics (1998) 51:14–20.
   PubMedGoogle Scholar
• KOGUCHI Y, ASAI Y, SUZUKI S et al. TMC-49A, a novel transcriptional up-regulator of low density lipoprotein receptor, produced by Streptomyces sp. A51345. J Antibiotics (1998) 51:107–111.
   Google Scholar
• NESS GC: Thyroid hormone. Basis for its hypocholes-terolemic effect. J. Fla. Med. Assoc. (1991) 78:383–385.
   PubMedGoogle Scholar
• TAYLOR AH, STEPHAN ZF, STEELE RE, WONG NCW: Beneficial effects of a novel thyromimetic on lipopro-tein metabolism. Mol. Pharmacol (1997) 52:542–547.
   PubMed Web of Science ®Google Scholar
• •Paper describing cardiac-sparing thyromimetics.
   Google Scholar
• YOKOYAMA N, WALKER GN, MAIN AJ et al.: Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to t-thyronine. Med. Chem. (1995) 38:695–707.
   Google Scholar
• SAKAI J, RAWSON RB, ESPENSHADE PJ et al.: Molecular identification of the sterol-regulated luminal protease that cleaves SREPBs and controls lipid composition of animal cells. Mol Cell (1998) 2:505–514.
   PubMed Web of Science ®Google Scholar